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ABSTRACT Cholecystokinin (CCK) is a regu-
latory peptide that is primarily expressed in two
adult cell types: endocrine cells of the intestine
and neurons of the central nervous system. To
determine the ontogeny of CCK expression dur-
ing intestinal organogenesis, we created a mouse
strain in which the CCK gene was replaced by a
lacZ reporter cassette using homologous recombi-
nation in embryonic stem cells. Initially, CCK
expression in the developing intestine was lim-
ited to the myenteric plexus of the enteric ner-
vous system. This expression pattern was wide-
spread, extending from the proximal stomach
into the colon, yet transient, being detected soon
after gut tube closure [embryonic day 10.5 (E10.5)]
through E15.5. Since enteric neurons are derived
from the neural crest, we examined earlier (E8.5–
9.5) embryos and concluded that lacZ was ex-
pressed in subpopulations of neural tube and
neural crest cells. Endocrine cell expression
in the intestinal epithelium occurred later, begin-
ning at E15.5 as enteric neuronal expression was
dwindling. This expression persisted to yield
the adult pattern of scattered single endocrine
cells in the upper small intestine. The data show
that CCK is a very early marker of both neuronal
and endocrine cell lineages in the developing
gastrointestinal tract. Furthermore, reverse
transcriptase polymerase chain reaction (RT-
PCR) analysis showed that CCK receptor tran-
scripts were detected in embryos as early as
E10.5, suggesting that CCK signaling is estab-
lished early in mouse development. Dev Dyn
1999;216:190–200. r 1999 Wiley-Liss, Inc.
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INTRODUCTION
Cholecystokinin (CCK) is a regulatory peptide that is
produced in both the gastrointestinal tract and nervous
system. CCK secreted from endocrine cells in the
proximal small intestine acts as a hormone to stimulate
gallbladder contraction and pancreatic enzyme secre-
tion to regulate the flow of digestive juices into the
duodenum (Crawley and Corwin, 1994). Synthesis of
CCK also occurs in neurons of the central and periph-
eral nervous systems, where it functions as a neuro-
transmitter or neuromodulator (Beinfeld et al., 1981;
Schultzberg et al., 1980). Dual expression in neurons
and gastrointestinal endocrine cells is a feature com-
mon to several regulatory peptides, including somato-
statin, glucagon-like-peptide 1, and neurotensin. CCK
expression provides a paradigm to characterize the
molecular basis for the dual expression pattern in these
distinct cell lineages.
In the adult small intestine, CCK is produced in
endocrine cells within the mucosa and in a subset of
neurons in the enteric nervous system. These endocrine
cells and neurons are thought to arise from different
embryonic origins. Stem cells residing in the intestinal
crypts produce endocrine cells as well as the three other
lineages of the intestinal epithelium: enterocytes, gob-
let cells, and paneth cells (Cheng and Leblond, 1974;
Ponder et al., 1985). The intestinal stem cells are
believed to be of endodermal origin, however the means
by which the four cell lineages are specified is not well
understood. Moreover, there are numerous types of
endocrine cells defined by the hormone product they
secrete and the morphology of their secretory granules.
Little is known about the differentiation pathways or
lineage relationships between these different types of
intestinal endocrine cells. Two separate lineages of
colonic endocrine cells have been proposed (Roth et al.,
1992; Upchurch et al., 1996). One branch includes
peptide YY (PYY)-, glucagon-, neurotensin-, and CCK-
producing cells, and the other includes serotonin- and
substance P-producing cells. Recent data from mouse
mutants deficient in the basic helix loop helix transcrip-
tion factor BETA2/NeuroD suggested that distinct endo-
crine lineages may also exist in the small intestine
(Naya et al., 1997). Both CCK-producing and secretin-
producing cells were absent in the BETA2/NeuroD
deficient mice, while other enteroendocrine cell popula-
tions (glucagon, PYY, neurotensin, substance P, gastric
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inhibitory peptide, and somatostatin) were relatively
unaffected, suggesting that there may be a close lineage
relationship between CCK- and secretin-producing cells.
The neurons and glia of the enteric nervous system
are derived from migratory neural crest cells that
colonize the gut (Le Douarin and Teillet, 1973; Le
Douarin, 1986; Pomeranz et al., 1991). During mouse
development, neural crest cells detach from the dorsal
portion of the neural folds and migrate along predeter-
mined routes to establish a number of different cell
types, including melanocytes, adrenal medullary cells,
skeletal and connective tissue components of the head,
and the neurons and glia of the peripheral nervous
system. Enteric ganglia are derived primarily from the
vagal neural crest that originates from the level of
somites 1–7 (Le Douarin and Teillet, 1973), but some
cells arise from the sacral crest (caudal to somite 28)
(Pomeranz et al., 1991; Serbedzija et al., 1991). When
the neural crest cells reach their target tissue, they
differentiate into a number of neuronal and non-
neuronal cell types. In the adult enteric nervous sys-
tem, CCK neurons are most abundant in the colon, with
lower numbers found in the small intestine (Larsson
and Rehfeld, 1979; Schultzberg et al., 1980). CCK
neurons are found in both the myenteric plexus and
submucosal plexus. Although CCK is detectable in the
enteric nervous system, most of the CCK in the adult
gastrointestinal tract is produced by endocrine cells.
While the pattern of CCK expression in neurons and
endocrine cells of the adult intestine has been well
characterized, the ontogeny of this expression is less
clear. In this study, we have replaced part of the mouse
CCK gene (Cck) with a bacterial b-galactosidase re-
porter cassette by homologous recombination in embry-
onic stem (ES) cells. We analyzed lacZ expression in
heterozygous fetuses collected from timed matings to
study the timing and sites of appearance of CCK-
expressing cells during development. We asked when
during intestinal morphogenesis CCK-expressing endo-
crine cells and neurons are first formed.
RESULTS
Generation of CcklacZ Mice
Homologous recombination in embryonic stem (ES)
cells was used to construct a mutant mouse that
expressed the bacterial lacZ reporter gene under the
control of the CCK promoter (Fig. 1). The targeting
vector was engineered such that the lacZ gene product,
b-galactosidase, initiated at the normal CCK transla-
tional start site in exon 2. The CCK gene was further
disabled by a 168-bp deletion at the site of the lacZ
insertion. After electroporation of the targeting vector
into ES cells, correctly targeted clones were identified
by polymerase chain reaction (PCR) and Southern blot
analysis. The CcklacZ mutation was subsequently trans-
Fig. 1. Targeted insertion of the lacZ reporter gene into the mouse
CCK gene. (A) Schematic diagram of the targeting vector (top), the
mouse CCK gene (middle), and the mutant allele generated after
homologous recombination (bottom). The mouse CCK gene contains 3
exons, the first a non-coding exon. A replacement-type targeting vector
was constructed containing the bacterial lacZ reporter gene fused to the
CCK gene at the translational start site in exon 2. B 5 BamHI; S 5 SalI.
(B) Genomic Southern analysis on DNAs isolated from wild type (1/1),
heterozygous (1/2), and homozygous mutant (2/2) mice. The probe
and predicted BamHI fragments of the wild type (7.9 kb) and mutant (12
kb) alleles are indicated in (A). (C) CCK transcripts are absent in tissues
from homozygous mutant mice. Northern blot analysis of total RNA (20
µg) isolated from brain or duodenum from wild-type (1/1) or homozygous
mutant (2/2) mice. The same blot was hybridized sequentially with a
CCK cDNA probe and a 28S ribosomal probe to control for loading.
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ferred to the mouse germline by microinjection of
targeted ES cell clones into blastocysts to generate
chimeric mice, which were bred to transmit the engi-
neered mutation to heterozygous progeny. Intercross-
ing heterozygous CcklacZ/1 mice produced the expected
1 : 2 : 1 ratio of wild-type : heterozygous: homozygous
mutant mice. Southern blot analysis of genomic DNA
isolated from mice of these three genotypes confirmed
the allele structures (Fig. 1B). Lack of CCK mRNA in
homozygous mutant mice was demonstrated by north-
ern blot analysis of brain and intestinal RNA (Fig. 1C),
and loss of CCK peptide was established by immunohis-
tochemistry with an anti-CCK antibody (Fig. 2). The
absence of CCK mRNA and protein confirms that
CcklacZ is a null allele.
CCK-deficient male and female mice were indistin-
guishable from their wild-type littermates at birth,
developed and gained weight at the same rate as
wild-type controls, and reached the same adult body
weight as wild-type controls (Lacourse et al., 1999). In
addition, both male and female CCK-deficient mice
were fertile, and females were able to bear and rear
their young. Thus, CCK is not required for viability or
fertility.
Reporter Gene Expression in Intestine
and Brain
In the adult small intestine, CCK is primarily pro-
duced in a subset of endocrine cells known as I cells.
These cells exist as scattered single cells in the epithe-
lium, most densely localized in the upper small intes-
tine. We confirmed accurate expression of the lacZ
reporter gene in I cells of CcklacZ mice by demonstrating
co-localization of CCK immunoreactivity and X-gal
staining in adult intestinal sections. In heterozygous
mice lacZ expression was only detected in CCK-
immunoreactive cells (Fig. 2A and B). In homozygous
mutant mice CCK immunoreactivity was not detected;
lacZ expressing cells were observed, with no obvious
difference in position or number in comparison to
heterozygotes (Fig. 2C and D).
CCK is expressed in many regions of the brain,
including olfactory bulb, cortex, thalamus, and hippo-
campus. We confirmed that the lacZ reporter gene was
expressed in the brains of adult CcklacZ mice by compar-
ing X-gal stained sections from heterozygous (Fig. 2E)
or homozygous (not shown) brains to wild-type sections
on which in situ hybridization had been performed to
detect CCK transcripts (Fig. 2F). This analysis was
limited to coronal sections in one region of the brain.
The X-gal staining and in situ hybridization patterns in
this region of the brain were similar, with expression
seen in cortex, hippocampus, and thalamus.
Two Patterns of CCK Expression During
Gastrointestinal Tract Development
To characterize the ontogeny of CCK-expressing cells
during intestinal organogenesis we determined the
Fig. 2. Verification of lacZ expression in CCK-expressing cells in adult
mice. (A–D) Sections of small intestine from heterozygous (A and B) and
homozygous (C and D) CcklacZ mice were co-stained with X-gal to detect
lacZ expression (A and C), and with an antibody to CCK (B and D). The
arrowheads indicate a single stained CCK-endocrine cell in each longitu-
dinal villus section. Scale bars represent 50 µm. (E–F) Sections of brain
from CcklacZ heterozygous (E) or wild-type (F) mice were either stained
with X-gal (E), or in situ hybridization was performed to detect Cck
transcripts using an 35S-labeled riboprobe (F). Expression is seen in both
preparations in the cortex (c), hippocampus (h), and thalamus (t), but not
in the dentate gyrus (dg). Scale bars 5 1 mm.
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pattern of lacZ expression in heterozygous (CcklacZ/1)
fetuses from timed matings. Whole-mount X-gal stain-
ing of gastrointestinal tracts showed extensive staining
in scattered single cells at both E14.5 and E16.5 (Fig.
3), while no staining was observed in control (1/1)
fetuses (not shown). However, the localization of X-gal
positive cells along the tracts differed significantly at
these two developmental time points. At E14.5, positive
cells were found along the majority of the length of the
tract, with staining extending from the esophageal/
stomach border into the proximal colon. This pattern is
in contrast to the more restricted pattern of staining at
E16.5, with X-gal positive cells concentrated in the
upper small intestine and no staining in the proximal
gastrointestinal tract, including esophagus and stom-
ach. Figure 3 summarizes the staining pattern along
the length of the gastrointestinal tract and shows a
high-power view of the stomach/duodenum border. At
E14.5 X-gal stained cells are distributed evenly across
this border (Fig 3A), while at E16.5 stained cells were
observed in the small intestine but not the stomach
(Fig. 3B).
To understand the cellular basis for the changing
pattern of expression in the developing gastrointestinal
tract, we examined cryosectioned embryos from E10.5
to birth (Fig. 4). Similar to the results described above
for whole-mount stained tissue, the pattern of staining
changed between E14.5 and E16.5. In the early period
(E10.5 to E14.5), expression in the gastrointestinal
tract was limited to cells in the mesenchyme surround-
ing the epithelium, while in the later time period (E15.5
to birth), staining was observed in epithelial cells. In
the early embryo, soon after the gut tube closes (E10.5),
a few positive cells appeared to be migrating into the
mesenchyme surrounding the tube (Fig 4A). Subse-
quently this staining was organized in a concentric ring
around the gut tube (Fig. 4B–E). Because this early
expression had not been previously described for CCK,
we verified the expression pattern by in situ hybridiza-
tion of E12.5 embryo sections with a CCK antisense
riboprobe (Fig. 4C).
At E15.5, the submucosal staining was still present,
however X-gal positive cells were now apparent in the
intestinal epithelium on the nascent villi (Fig. 4F and
G). By E16.5, the submucosal staining had diminished,
but the epithelial staining on the developing villi
persisted. Immunohistochemical analysis of E16.5 em-
bryos with a CCK antibody demonstrated that the
X-gal positive epithelial cells synthesize CCK protein
(Fig. 4J). The epithelial expression pattern was main-
tained during intestinal organogenesis as villi and
crypts are formed, to become the characteristic I cell
expression pattern observed in the adult (compare Fig.
4I with Fig. 2A).
Fig. 3. CcklacZ expression in embryonic gastrointestinal tract. Gastro-
intestinal tracts from E14.5 (A,C) or E16.5 (B,D) were dissected and
stained as whole-mounts with X-gal. (A) A view of the stomach/intestinal
junction (arrow) at E14.5 shows X-gal stained blue cells extending
throughout the stomach and intestine. (B) A similar view at E16.5 shows
that the blue-stained cells are restricted to the intestine. (C,D) Schematic
diagrams of the X-gal staining pattern of gastrointestinal tracts of E14.5
(C) or E16.5 (D) embryos. The dashed boxes indicate the general regions
shown in the high powered views of tissues (A,B). Labels: e, esophagus;
s, stomach; i, intestine; c, cecum; co, colon. Scale bars 5 170 µm.
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Early Embryonic Expression in Developing
Enteric Nervous System
The positioning of the CCK-expressing cells in the
early embryo in a concentric ring around the gut tube
suggested that these cells may be a component of the
developing nervous system in the wall of the gastroin-
testinal tract. To test this we co-stained E14.5 embryo
sections with X-gal and an antibody to the neurofila-
ment protein peripherin. The results showed that the
X-gal positive cells were positioned within the neuronal
processes (Fig 5A–C). Co-staining with X-gal and rhoda-
mine-phalloidin, to identify muscle, showed that the
lacZ-expressing cells were just exterior to the muscle
layer (Fig. 5D–F). Positioning in the neuronal network
just exterior to the muscle indicates that the CCK-
expressing cells in the early embryo are in the develop-
ing myenteric plexus of the enteric nervous system.
Expression in Neural Crest
The enteric nervous system is derived from neural
crest cells that migrate from the dorsal region of the
neural tube into the gut. We examined E8.5 and E9.5
Fig. 4. Localization of lacZ expressing cells within the prenatal
intestine. Expression was first seen in the mesenchyme surrounding the
gut tube (A–F), and later in enteroendocrine cells located in the epithelium
(e) (F–J). Arrows indicate some of the positive cells. (A) E10.5 heterozy-
gous embryo. (B–C) E12.5. A heterozygous (B) embryo shows staining in
the developing enteric nervous system. In situ hybridization with a
digoxigenin-labeled antisense CCK riboprobe on a wild type embryo
(C) detects the same pattern of staining. There was no hybridization
observed with control experiments using a sense riboprobe (not shown).
(D–E) E14.5 heterozygous embryo at lower (D) and higher (E) magnifica-
tion. (F–G) E15.5 heterozygous embryos. Staining is apparent in both
enteric nervous system and developing endocrine cells. (G) shows a
higher magnification view of the endocrine expression on developing villi.
(H–J) E16.5 heterozygous embryos. Lower magnification (H) or higher
magnification (I) views show that expression is restricted to the intestinal
epithelium. A wild-type section (J) stained with an anti-CCK antibody
shows that peptide is detected in the same pattern as X-gal staining.
Scale bars 5 70 µm (A, B, C, D, F and H) or 30 µm (E, G, I, J).
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embryos to determine whether there was lacZ expres-
sion in neural tube and migratory neural crest. Whole-
mount X-gal staining revealed extensive expression in
early embryos (Fig. 6). At E8.5, X-gal staining was
observed in the neural tube, brain, and heart. Sections
showed the neural tube staining to be in the dorsal
region of the neural folds, consistent with the position
of the early neural crest (Fig. 6B). At E9.5 staining in
the neural tube is quite extensive, extending caudally
down the neural tube as development continues (Fig.
6C). Sections of E9.5 embryos also showed that the
neural tube staining is restricted to the dorsal region,
from which neural crest cells detach and migrate to
various destinations in the body (Fig. 6D). Other re-
gions of staining consistent with neural crest include
the dermamyotome and sympathetic chain ganglia.
However, expression of CcklacZ was not detected in all
neural crest cells or derivatives; for example, staining
of dorsal root ganglia was not observed. Moreover, the
neural crest/neural tube staining extended beyond the
region from which the progenitors of the enteric ner-
vous system originate.
Ontogeny of CCK-Family Ligands and Receptors
The patterns of expression of the endogenous CCK
gene and its two receptors were examined by reverse
transcriptase PCR (RT-PCR) analysis of total RNA
isolated from embryos aged E8.5 to E17.5. In agree-
ment with the X-gal staining results, CCK transcripts
were detected at all stages examined (Fig. 7). Analysis
of RNAfrom individual tissues of E17.5 embryos demon-
strated that CCK transcripts were present in pancreas,
intestine, and head, but not liver. To determine if CCK
receptor transcripts were also present during mouse
embryogenesis, we used primers specific for CCK-A
receptor and CCK-B/gastrin receptor transcripts. Both
receptor transcripts were detected as early as E10.5,
and showed the same tissue specificity at E17.5 as
CCK, with expression detected in pancreas, intestine,
and head, but not liver. Similar to the timing of the
receptors, transcripts for gastrin, the other CCK-family
Fig. 5. CcklacZ is expressed in
the enteric nervous system of
E14.5 embryos. (A–C) High mag-
nification view of a section co-
stained with X-gal (A, C) and a
peripherin antibody (B, C). An
overlay (C) of photos A and B
shows colocalization of X-gal and
peripherin staining. (D–F). A sec-
tion co-stained with X-gal (D, F)
and rhodamine-phalloidin (E, F).
An overlay (F) of photos D and E
demonstrates that the X-gal
stained blue cells are in the myen-
teric plexus, external to the phal-
loidin-stained smooth muscle layer.
The gut epithelium is indicated by
(e); arrows indicate some of the
positive cells. Scale bars 5 35 µm
(A) or 100 µm (D).
195CCK IN NEURONAL AND ENDOCRINE LINEAGES
ligand, were first detected at E10.5, with expression
continuing through birth.
Since it has been suggested that CCK- and secretin-
producing cells in the gut share a common lineage
pathway, we also examined the ontogeny of secretin
expression. RT-PCR analysis showed that secretin tran-
scripts were present very early in development, similar
to the timing of CCK gene expression in embryos as
early as E8.5 (Fig. 7).
DISCUSSION
We have utilized a new mouse strain with a lacZ
reporter cassette inserted into the CCK gene to study
the spatial and temporal pattern of CCK gene expres-
sion during intestinal organogenesis. The cellular pat-
tern of CCK expression was easily determined by
histochemical staining for the lacZ gene product b-ga-
lactosidase. Our studies demonstrate that CCK is ex-
pressed in developing neurons and endocrine cells in a
complex pattern. Expression in mouse intestine as
early as E14 was previously shown by Vitale et al.
(1991) by RNase protection assay. Our results show
that CCK-expressing cells can be found in the intestine
as early as E10.5. The early (E10.5–E14.5) gut expres-
sion is limited to developing neurons of the myenteric
plexus of the enteric nervous system. This widespread
expression in the developing enteric nervous system is
transient, ending just after endocrine expression is first
detected at E15.5. It is not clear whether the cessation
of expression represents down-regulation of CCK tran-
scription within these cells, or whether these cells are
eliminated. Once activated, the endocrine expression
pattern persists through intestinal morphogenesis to
yield the adult pattern in scattered single cells in the
intestinal epithelium. The detection of endocrine CCK
several days before birth, at the time of rudimentary
villus formation, indicates that CCK gene expression is
Fig. 6. CcklacZ expression in whole-mount X-gal
stained embryos. (A) Staining in the neural tube
and midbrain (mb) (unlabeled arrows), and heart (h)
and somites (s) are seen in an E8.5 embryo. (B) A
cryosection of an E8.5 embryo exhibits staining in
neural epithelium (ne) in the dorsal region of the
neural folds (arrow). (C) An E9.5 embryo shows
more extensive neural tube staining, and expres-
sion in midbrain, hindbrain (hb), heart and dermo-
myotome (d). Hindbrain expression is localized to
rhombomeres 2 and 4. (D) A cryosection of an E9.5
embryo reveals that the neural tube staining is
restricted to the dorsal region of the neural epithe-
lium where neural crest cells originate. Staining is
also seen in the dermomyotome and sympathetic
chain (sc). Scale bars 5 100 µm.
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an extremely early event in enteroendocrine cell differ-
entiation.
We detected extensive lacZ expression in the neuro-
epithelium of the early embryos (E8.5–E9.5), including
the dorsal neural tube, consistent with neural crest
expression. Expression in neural crest is significant for
several reasons. First, CCK expression in the develop-
ing enteric nervous system may initiate in the neural
tube in neural crest cells that continue to express CCK
as they migrate to the gut. Second, the neural crest has
been difficult to study in the mouse, due to a lack of
reliable cellular markers. CCK gene expression may
represent a marker for a certain subpopulation of
neural crest cells that may be useful for future studies.
Furthermore, it appears that secretin, another gastroin-
testinal peptide, is also expressed in embryos as early
as E8.5. Since we demonstrated the presence of the
secretin transcript in whole embryo RNA preparations,
it remains to be determined whether the secretin gene
is also transcribed in the neural tube/neural crest in a
pattern similar to CCK.
Basic helix-loop-helix transcription factors play an
important role in the cell-specific expression of genes
and in the determination and differentiation of cells in
various lineages. BETA2/NeuroD is a basic helix-loop-
helix transcription factor that is expressed specifically
in subsets of differentiating neurons and in endocrine
cells (Lee et al., 1995; Naya et al., 1995). This transcrip-
tion factor has been shown to activate secretin transcrip-
tion (Mutoh et al., 1997). BETA2/NeuroD-deficient mice
specifically lack both secretin and CCK intestinal endo-
crine lineages, while retaining others (Naya et al.,
1997). We have determined that loss of CCK does not
affect secretin transcript levels and that endocrine cells
expressing CcklacZ do not produce secretin in place of
CCK (not shown). Thus in CCK-deficient mice, both the
CCK and secretin endocrine cell lineages are present.
Future experiments will address whether BETA2/
NeuroD directly activates CCK expression, and the role
that BETA2/NeuroD may play in the differentiation of
CCK-expressing endocrine cells and neurons.
In order to verify the expression pattern of the CcklacZ
allele, we initially confirmed that expression in adult
small intestine and brain was identical to expression of
the wild-type CCK gene by immunohistochemistry and
in situ hybridization. We verified the embryonic expres-
sion pattern in several ways. The presence of CCK
transcripts in embryos as early as E8.5 was verified by
RT-PCR. The cellular pattern of X-gal staining in
developing enteric neurons and endocrine cells was
confirmed by in situ hybridization and immunohisto-
chemistry, respectively. While the CcklacZ expression
and in situ hybridization represent transcription of the
CCK gene, our studies did not test whether bioactive
CCK peptide is produced. In order for CCK to be
functionally active, the transcript must be translated
and then the pro-peptide must be processed by a
number of different processing enzymes. Our results do
demonstrate that expression of the CcklacZ allele in
neuronal lineages and intestinal endocrine cells ap-
pears to represent the true pattern of expression of the
endogenous CCK gene.
Despite the widespread prenatal expression of CCK,
the consequences of CCK deficiency were not apparent.
The CCK-deficient male and female mice appeared to
develop normally, and CCK was not required for viabil-
Fig. 7. Expression of CCK and related tran-
scripts in embryogenesis. Samples of total RNA
from either whole embryos (lanes 1–4), or individual
tissues (lanes 5–9), or a negative water control
(lane 10) were analyzed by RT-PCR. Primers were
designed to detect transcripts for CCK, CCK-A
receptor (CCK-AR), CCK-B receptor (CCK-BR),
gastrin, secretin, and c-abl, as a positive control.
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ity or fertility (Lacourse et al., 1999). Homozygous
CCK-deficient embryos also expressed lacZ in the same
patterns and were indistinguishable from heterozygous
embryos. Thus, although CCK appears to be expressed
early in developing neurons and endocrine cells, it does
not appear to be necessary for their differentiation. As a
secreted peptide, CCK requires receptors in order to
function. We have demonstrated that transcripts for
both CCK receptors are present as early as E10.5. The
detection of CCK-A receptor and CCK-B/gastrin recep-
tor transcripts suggests that fetal CCK may have
previously undescribed functions that are difficult to
detect phenotypically or are compensated for. While the
CCK-B/gastrin receptor mediates the actions of both
CCK and gastrin, CCK is the only known ligand for the
CCK-A receptor. CCK-A receptor-deficient mice have
been recently reported (Kopin et al., 1999). In agree-
ment with our analysis of CCK-deficient mice, CCK-A
receptor-deficient mice develop without visible abnor-
malities. Gastrin-deficient and CCK-B/gastrin-receptor
deficient mice also develop grossly normally, although
they have significant defects in the maturation of cells
in the stomach involved with acid secretion (Nagata et
al., 1996; Koh et al., 1997; Langhans et al., 1997;
Friis-Hansen et al., 1998). Double mutant mice gener-
ated by crossing the CCK-deficient mice reported here
to the gastrin-deficient mice reported in Friis-Hansen
et al. (1998) also developed grossly normally (data not
shown), demonstrating that although both CCK and
gastrin are expressed early in embryogenesis, CCK-
family peptides are not required for murine develop-
ment.
EXPERIMENTAL PROCEDURES
Gene Targeting in ES Cells
The CCK targeting vector contained the bacterial
lacZ reporter from plasmid pCH110 (Pharmacia, Gai-
thersburg, MD) and a neomycin selection cassette from
plasmid pPNT (Tybulewicz et al., 1991) inserted into
exon 2 of Cck. The lacZ reporter was introduced at the
CCK translational start, at the site of a 168 bp deletion
which removed the N-terminus, including the signal
sequence for CCK (Fig. 1).
Mouse R1 ES cells (Nagy et al., 1993) were cultured
on neo-resistant mouse embryonic fibroblast feeder
cells in media supplemented with 103 units/ml of mu-
rine recombinant leukemia inhibitory factor (ESGRO;
Life Technologies Inc., Bethesda, MD) as described
(Friis-Hansen et al., 1998). After electroporation of the
CCK targeting vector into R1 cells, colonies were se-
lected in G418 (300 µg/ml) and isolated in individual
wells of a 96-well culture dish. Genomic DNA was
prepared (Ramirez-Solis et al., 1992) and colonies were
screened using the polymerase chain reaction (PCR)
with primers TS-Neo (58CGCCTTCTATCGCCTTCTT-
GACGAGTTCTT) and TS-CCK (58TTCTAGGAGACT-
CAACCAGGAGGTCCAGGT), to amplify a 1.5 kb prod-
uct from targeted ES cells. Homologous recombination
events were confirmed by Southern blotting and long-
range PCR as described (Lay et al., 1998). Six correctly
targeted clones were microinjected into C57BL/6J blas-
tocysts, with three clones yielding chimeric mice that
transmitted the targeted mutation through the germ-
line. Chimeras were bred to C57BL/6J or 129/SvJ mice
resulting in heterozygous CCK-deficient mice.
Southern Blot Analysis
Genomic DNA isolated from mouse tails was digested
overnight with BamHI, and Southern blotting was
performed as described (Samuelson et al., 1995). The
probe was a 0.7 kb EcoRI/BglII genomic DNA fragment
from the 58 flanking region (Fig. 1) that was 32P-labeled
by random oligonucleotide priming. Final wash condi-
tions were 0.13 standard saline citrate (SSC) and 0.1%
sodium dodecyl sulfate (SDS) at 60°C.
Genotyping of Mice or Embryos
Genotyping was done by multiplex PCR using three
primers to detect the wild type (CS1: 58 CTGGT-
TAGAAGAGAGATGAGCTACAAAGGC and CS2: 58
TAGGACTGCCATCACCACGCACAGACATAC) or tar-
geted (CS1 and LZ: 58 TGTAGATGGGCGCATCGTAAC-
CGTGCATCT) alleles. PCR reactions (50 µl) included
approximately 100–500 ng of mouse genomic DNA, 200
µM dNTPs, 0.4 µM of primers CS1 and CS2, 0.1 µM of
primer LZ, 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 4 mM
MgCl2, 0.01% (wt/vol) bovine serum albumin and Taq
polymerase. The cycle parameters were: (i) 94°C 5 min;
(ii) 35 cycles of 94°C 30 sec, 65°C 30 sec, 72°C 45 sec; (iii)
72°C 5 min. Amplification products of 361 bp (wild type)
and 454 bp (targeted) were detected by electrophoresis
in 2% agarose with ethidium bromide staining.
RNA Preparation and Northern Blot Analysis
Total RNA was isolated from mouse tissues using
either a guanidine thiocyanate homogenization/CsCl
centrifugation procedure (Samuelson et al., 1988) or
Trizol reagent (Life Technologies Inc.). Total RNA (20
µg) was electrophoresed in gels containing 2.2 M form-
aldehyde, transferred to Zeta-probe membrane (Bio-
Rad) and hybridized with 32P-labeled probes. Probes
used were a 173 bp PstI fragment of the mouse CCK
cDNA (bases 142–315) and a 28S ribosomal RNA probe
(Ambion). Imaging and quantitation were performed on
a GS-505 Molecular Imager (Bio-Rad, Hercules, CA).
X-gal Staining
Heterozygous embryos were obtained from matings
between heterozygous (CcklacZ /1) males and wild-type
(CD1) females. Noon on the day of presence of a vaginal
plug was taken to be embryonic day 0.5 (E0.5). Yolk sacs
or tails were taken for genotyping as described above.
For X-gal stained sections, embryos were removed and
fixed in 4% paraformaldehyde at 4°C, frozen in OCT
(Tissue-Tek), and cryosections (12 µm) were thaw
mounted onto poly-L-lysine coated slides. Slides were
fixed for 5 min in 0.2% glutaraldehyde at room tempera-
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ture and stained overnight at 30°C in 0.1 M sodium
phosphate pH 7.3, 5 mM potassium ferrocyanide, 5 mM
potassium ferricyanide, 2 mM MgCl2, 0.02% NP-40,
and 1 mg/ml 5-bromo-4-chloro-3-indolyl-b-D-galactopy-
ranoside (X-gal) (Boehringer Mannheim). Slides were
counterstained with 0.5% neutral red, dehydrated, and
coverslipped using Permount (Fisher Scientific, Fair-
lawn, NJ).
For X-gal stained whole-mount embryos or gastroin-
testinal tracts, the embryos or tissues were removed
and fixed in 4% paraformaldehyde for 15–30 min, and
stained 4 hr or overnight at 30°C, as described above.
Immunohistochemistry
Cryosections were fixed briefly in 4% paraformalde-
hyde, then X-gal stained as described above. The sec-
tions were blocked with 10% non-immune serum, then
incubated with the primary antibody for either 2 hr at
room temperature or at 4°C overnight. The following
primary antibodies were used: rabbit anti-peripherin
(1 : 1,000; AB1530, Chemicon International, Temecula,
CA) and rabbit anti-CCK (1 : 4,000; AB1972, Chemicon).
Primary antibodies were detected by immunofluores-
cent labeling with a Cy3-conjugated donkey anti-rabbit
IgG secondary antibody (Jackson ImmunoResearch
Laboratories, West Grove, PA). No fluorescence was
seen in controls stained with non-immune serum (not
shown). The CCK antibody has been shown to be
specific for CCK, by preabsorbing with CCK-33 before
staining (Liddle et al., 1992). Rhodamine-phalloidin
(Sigma Chemical Co., St. Louis, MO) was used with no
secondary antibody for staining muscle actin. Photo-
graphs were taken using an Aristoplan fluorescence
microscope (Leitz, Wetzlar, Germany).
In Situ Hybridization
Sense and antisense riboprobes were generated from
a 0.7-kb BglII fragment of Cck containing exon 3 cloned
into the pBluescript vector (Stratagene, La Jolla, CA).
Riboprobes were either labeled with 35S or with digoxi-
genin, and hybridized to cryosections overnight at
55°C. The final wash was performed in 0.13 SSC at
70°C. 35S-labeled slides were dehydrated and dipped in
NTB-2 emulsion (Kodak, Rochester, NY) diluted 1 : 1
with water, exposed for 1 week, developed and counter-
stained with cresyl violet (Sigma). Digoxigenin-labeled
slides were incubated with alkaline phosphatase-
conjugated anti-digoxigenin Fab fragments (Boeh-
ringer Mannheim Biochemicals, Indianapolis, IN),
which was visualized using 0.2 mM 5-bromo-4-chloro-3-
indolyl phosphate and 0.2 mM nitroblue tetrazolium
salt (Boehringer Mannheim).
RT-PCR
Reverse transcriptase reactions were performed with
2 µg of total RNA using the Superscript II RT Kit (Life
Technologies, Inc.) with an oligo(dT) primer for the first
strand synthesis. PCR reactions contained 10 mM
Tris-HCl (pH 8.0), 50 mM KCl, 3 mM MgCl2, 0.01%
bovine serum albumin, 0.2 mM dNTPs, Taq polymer-









58CATCTGGGTGGCCTGGTTGTTTCA), and c-abl (58TT-
TATGGGGCAGCAGCCTGGAAAAGTACTTGGG and
58TCACTGGGTCCAGCGAGAAGGTTTTCCTTGGAG-
TT). The PCR product sizes for the various genes are as
follows: CCK, 470 bp (Vitale et al., 1991); CCK-AR, 1.25
kb (Lacourse et al., 1997); CCK-BR, 543 bp (GenBank
Accession No. AF019371); gastrin, 318 bp (Friis-
Hansen et al., 1996); secretin, 384 bp (Lan et al., 1994);
and c-abl, 239 bp (Ben-Neriah et al., 1986). The RT-PCR
products were detected by electrophoresis in agarose
with ethidium bromide staining.
ACKNOWLEDGMENTS
We thank K.S. O’Shea for extensive advice and
discussions, L. Swanberg for technical assistance, S.
Camper for helpful support, J. Friedman (Rockefeller
University) for the mouse CCK genomic clone, and J.
Rossant and A. Nagy (University of Toronto) for R1 ES
cells. We also acknowledge T. Saunders and the Univer-
sity of Michigan Transgenic Animal Core, and the
Organogenesis Morphology Core. This work was sup-
ported by grants from the University of Michigan
Peptide Research Center, Cancer Center and Diabetes
Center, and the National Institutes of Health to LCS;
JML was supported by the Cellular Molecular Biology
Training Grant (5T32GM07315) and by the Organogen-
esis Training Grant (HD07505), both from the NIH.
REFERENCES
Beinfeld MC, Meyer DK, Eskay RL, Jensen RT, Brownstein MJ. 1981.
The distribution of cholecystokinin immunoreactivity in the central
nervous system of the rat as determined by radioimmunoassay.
Brain Res 212:51–57.
Ben-Neriah Y, Bernards A, Paskind M, Daley GQ, Baltimore D. 1986.
Alternative 58exons in c-abl mRNA. Cell 44:577–586.
Cheng H, Leblond CP. 1974. Origin, differentiation and renewal of the
four main epithelial cell types in the mouse small intestine. III.
Entero-endocrine cells. Am J Anat 141:503–519.
Crawley JN, Corwin RL. 1994. Biological actions of cholecystokinin.
Peptides 15:731–755.
Dudov KP, Perry RP. 1984. The gene family encoding the mouse
ribosomal protein L32 contains a uniquely expressed intron-
containing gene and an unmutated processed gene. Cell 37:457–468.
Friis-Hansen L, Rourke IJ, Bundgaard JR, Rehfeld JF, Samuelson LC.
1996. Molecular structure and genetic mapping of the mouse gastrin
gene. FEBS Lett 386:128–132.
Friis-Hansen L, Sundler F., Li Y, Gillespie PJ, Saunders TL, Greenson
JK, Owyang C, Rehfeld JF, Samuelson LC. 1998. Impaired gastric
acid secretion in gastrin-deficient mice. Am J Physiol 274:G561–
G568.
Koh TJ, Goldenring JR, Ito S, Mashimo H, Kopin AS, Varro A, Dockray
GJ, Wang TC. 1997. Gastrin deficiency results in altered gastric
differentiation and decreased colonic proliferation in mice. Gastroen-
terology 113:1015–1025.
199CCK IN NEURONAL AND ENDOCRINE LINEAGES
Kopin AS, Mathes WF, McBride EW, Nguyen M, Al-Haider W, Schmitz
F, Bonner-Weir S, Kanarek R, Beinborn M. 1999. The cholecystoki-
nin-A receptor mediates inhibition of food intake yet is not essential
for the maintenance of body weight. J Clin Invest 103:383–391.
Lacourse KA, Lay JM, Swanberg LJ, Jenkins C, Samuelson LC. 1997.
Molecular structure of the mouse CCK-A receptor gene. Biochem
Biophys Res Commun 236:630–635.
Lacourse KA, Swanberg LJ, Gillespie PJ, Rehfeld JF, Saunders TL,
Samuelson LC. 1999. Pancreatic function in CCK-deficient mice:
adaptation to dietary protein does not require CCK. Am J Physiol
276:G1302–1309.
Lan MS, Kajiyama W, Donadel G, Lu J, Notkins AL. 1994. cDNA
sequence and genomic organization of mouse secretin. Biochem
Biophys Res Commun 200:1066–1071.
Langhans N, Rindi G, Chiu M, Rehfeld JF, Ardman B, Beinborn M,
Kopin AS. 1997. Abnormal gastric histology and decreased acid
production in cholecystokinin-B/gastrin receptor-deficient mice. Gas-
troenterology 112:280–286.
Larsson LI, Rehfeld JF. 1979. Localization and molecular heterogene-
ity of cholecystokinin in the central and peripheral nervous system.
Brain Res 165:201–218.
Lay JM, Friis-Hansen L, Gillespie PJ, Samuelson LC. 1998. Rapid
confirmation of gene targeting in embryonic stem cells using two
long-range PCR techniques. Transgenic Res 7:135–140.
Le Douarin NM, Teillet MA. 1973. The migration of neural crest cells
to the wall of the digestive tract in avian embryo. J Embrol Exp
Morphol 30:31–48.
Le Douarin NM. 1986. Cell line segregation during peripheral nervous
system ontogeny. Science 231:1515–1522.
Lee JE, Hollenberg SM, Snider L, Turner DL, Lipnick N, Weintraub H.
1995. Conversion of Xenopus ectoderm into neurons by NeuroD, a
basic helix-loop-helix protein. Science 268:836–844.
Liddle RA, Misukonis MA, Pacy L, Balber AE. 1992. Cholecystokinin
cells purified by fluorescence-activated cell sorting respond to
monitor peptide with an increase in intracellular calcium. Proc Natl
Acad Sci USA 89:5147–5151.
Mutoh H, Fung BP, Naya FJ, Tsai MJ, Nishitani J, Leiter AB. 1997.
The basic helix-loop-helix transcription factor BETA2/NeuroD is
expressed in mammalian enteroendocrine cells and activates secre-
tin gene expression. Proc Natl Acad Sci USA 94:3560–3564.
Nagata A, Ito M, Iwata N, Kuno J, Takano H, Minowa O, Chihara K,
Matsui T, Noda T. 1996. G protein-coupled cholecystokinin-B/
gastrin receptors are responsible for physiological cell growth of the
stomach mucosa in vivo. Proc Natl Acad Sci USA 93:11825–11830.
Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC. 1993.
Derivation of completely cell culture-derived mice from early-
passage embryonic stem cells. Proc Natl Acad Sci USA 90:8424–8428.
Naya FJ, Stellrecht CM, Tsai MJ. 1995. Tissue-specific regulation of
the insulin gene by a novel basic helix-loop-helix transcription
factor. Genes Dev 9:1009–1019.
Naya FJ, Huang HP, Qiu Y, Mutoh H, DeMayo FJ, Leiter AB, Tsai MJ.
1997. Diabetes, defective pancreatic morphogenesis, and abnormal
enteroendocrine differentiation in BETA2/neuroD-deficient mice.
Genes Dev 11:2323–2334.
Pomeranz HD, Rothman TP, Gershon MD. 1991. Colonization of the
post-umbilical bowel by cells derived from the sacral neural crest:
direct tracing of cell migration using an intercalating probe and a
replication-deficient retrovirus. Development 111:647–655.
Ponder BA, Schmidt GH, Wilkinson MM, Wood MJ, Monk M, Reid A.
1985. Derivation of mouse intestinal crypts from single progenitor
cells. Nature 313:689–691.
Ramirez-Solis R, Rivera-Perez J, Wallace JD, Wims M, Zheng H,
Bradley A. 1992. Genomic DNA microextraction: a method to screen
numerous samples. Anal Biochem 201:331–335.
Roth KA, Kim S, Gordon JI. 1992. Immunocytochemical studies
suggest two pathways for enteroendocrine cell differentiation in the
colon. Am J Physiol 263:G174–G180.
Samuelson LC, Keller PR, Darlington GJ, Meisler MH. 1988. Glucocor-
ticoid and developmental regulation of amylase mRNAs in mouse
liver cells. Mol Cell Biol 8:3857–3863.
Samuelson LC, Isakoff MS, Lacourse KA. 1995. Localization of the
murine cholecystokinin A and B receptor genes. Mamm Genome
6:242–246.
Schultzberg M, Hokfelt T, Nilsson G, Terenius L, Rehfeld JF, Brown M,
Elde R, Goldstein M, Said S. 1980. Distribution of peptide- and
catecholamine-containing neurons in the gastro-intestinal tract of
rat and guinea-pig: immunohistochemical studies with antisera to
substance P, vasoactive intestinal polypeptide, enkephalins, somato-
statin, gastrin/cholecystokinin, neurotensin and dopamine beta-
hydroxylase. Neuroscience 5:689–744.
Serbedzija GN, Burgan S, Fraser SE, Bronner-Fraser M. 1991. Vital
dye labeling demonstrates a sacral neural crest contribution to the
enteric nervous system of chick and mouse embryos. Development
111:857–866.
Tybulewicz VL, Crawford CE, Jackson PK, Bronson RT, Mulligan RC.
1991. Neonatal lethality and lymphopenia in mice with a homozy-
gous disruption of the c-abl proto-oncogene. Cell 65:1153–1163.
Upchurch BH, Fung BP, Rindi G, Ronco A, Leiter AB. 1996. Peptide YY
expression is an early event in colonic endocrine cell differentiation:
evidence from normal and transgenic mice. Development 122:1157–
1163.
Vitale M, Vashishtha A, Linzer E, Powell DJ, Friedman JM. 1991.
Molecular cloning of the mouse CCK gene: expression in different
brain regions and during cortical development. Nucl Acids Res
19:169–177.
200 LAY ET AL.
